Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03400085 · ClinicalTrials.gov registry record · NA
Pilot Study of an mHealth Intervention for Living Donor Follow-up
A NA study of Nephrectomy and Living Donors, sponsored by Johns Hopkins University.
- Active
- Registry status
- NA
- Development phase
- 400
- Enrollment target
- 2
- Study locations
NCT03400085: Active NA study of Nephrectomy and Living Donors, sponsored by Johns Hopkins University.
NCT03400085 is a NA study of Nephrectomy and Living Donors that is active but no longer recruiting, run by Johns Hopkins University. The registered enrollment target is 400 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (72% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03400085, a NA study of Nephrectomy and Living Donors, is active but no longer recruiting, sponsored by Johns Hopkins University.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 400 participants
- Enrollment target
- 2
- Study locations
Study Summary
The investigators are interested in whether or not the use of a mobile health (mHealth) application increases the rate of follow-up compliance among living kidney donors. The investigators aim to test this by randomly assigning living kidney donors to the intervention (use of mHealth application to complete required living kidney donor follow-up at 6 months, 1 year, and 2 years) or control arm (standard of care) upon discharge from their initial donation hospitalization, and tracking follow-up compliance over time. The study population will be approximately 400 living kidney donors who undergo donor nephrectomy at Methodist Specialty and Transplant Hospital (200/year for 2 years). The investigators will also recruit patients from the Vanderbilt University Medical Center into the study, however, these study participants are not a part of the Pilot Randomized Clinical Trial (RCT).
Primary Outcome
Compliance with submitting questionnaires and laboratory values within 60 days of the six-month donation anniversary. Participants in the intervention arm will receive notifications when their follow-up is available to complete via the mHealth app, and subsequent notifications thereafter until either the donor completes both clinical and laboratory components of the required follow-up, or they are no longer compliant and within the 60-day window. Participants in the control arm will complete the
Conditions Studied
Interventions
- OTHER mHealth application
Study Locations (2)
Tennessee
- Vanderbilt University Medical Center - Nashville
Texas
- Methodist Specialty and Transplant Hospital - San Antonio
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 400 participants |
| Start Date | 2018-05-01 |
| Est. Completion | 2026-12-31 |
| Phase | NA |
What the registry record for NCT03400085 still lists
NCT03400085 is an interventional study that assigns participants to a tested intervention. The registered 400 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (72% lower).
The record links to 3 conditions, with Nephrectomy appearing as the primary indexed condition, and to 1 intervention - of which mHealth application is the first listed.
NCT03400085 reports a single indexed study location in Tennessee, Texas.
Frequently Asked Questions
What is clinical trial NCT03400085 about?
NCT03400085 is a clinical study titled "Pilot Study of an mHealth Intervention for Living Donor Follow-up". The investigators are interested in whether or not the use of a mobile health (mHealth) application increases the rate of follow-up compliance among living kidney donors. The investigators aim to test this by randomly assigning living kidney donors to the intervention (use of mHealth application to ...
What is the current status of trial NCT03400085?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 400 participants. The study started on 2018-05-01. Estimated completion is 2026-12-31.
What conditions does trial NCT03400085 study?
This clinical trial studies the following conditions: Nephrectomy, Living Donors, Kidney.
What interventions are being tested in trial NCT03400085?
The interventions under investigation include: mHealth application (OTHER).
Who is sponsoring clinical trial NCT03400085?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03400085 being conducted?
This trial has 2 study locations across Tennessee, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Nephrectomy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03400085's enrollment target sits among peer trials
400 246th of 2000 higher than 1,734 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01665326 · 400 participants
Determination of CRIM Status and Longitudinal Follow-up of Individuals With Pompe Disease
- NCT02108054 · 400 participants · NA
Behavioral and Functional Task Development, Implementation, and Testing
- NCT02216500 · 400 participants · NA
Ketogenic Therapy Effects on Electrical and Metabolic Abnormalities in Epilepsy
- NCT02250352 · 400 participants
Core Biopsies for Establishing a Breast Tumor Tissue Repository
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI